Items where authors include "Cid, MC"

Article

Ortiz-Fernández, L, Carmona, EG, Kerick, M et al. (22 more authors) (2023) Identification of new risk loci shared across systemic vasculitides points towards potential target genes for drug repurposing. Annals of the Rheumatic Diseases, 82 (6). pp. 837-847. ISSN 0003-4967

Ehlers, L, Askling, J, Bijlsma, HWJ et al. (17 more authors) (2019) 2018 EULAR recommendations for a core data set to support observational research and clinical care in giant cell arteritis. Annals of the Rheumatic Diseases, 78 (9). pp. 1160-1166. ISSN 0003-4967

Gonzalez-Serna, D, Carmona, EG, Ortego-Centeno, N et al. (26 more authors) (2018) A TNFSF13B functional variant is not involved in systemic sclerosis and giant cell arteritis susceptibility. PLoS ONE, 13 (12). e0209343. ISSN 1932-6203

Carmona, FD, Vaglio, A, Mackie, SL et al. (8 more authors) (2017) A Genome-Wide Association Study Identifies Plasminogen and P4HA2 as Novel Susceptibility Genes for Giant Cell Arteritis. Rheumatology, 56 (suppl_3). P1_30. iii53-iii53. ISSN 1462-0324

Carmona, DF, Vaglio, A, Mackie, SL orcid.org/0000-0003-2483-5873 et al. (53 more authors) (2017) A genome-wide association study identifies risk alleles in plasminogen and P4HA2 associated with giant cell arteritis. American Journal of Human Genetics, 100 (1). pp. 64-74. ISSN 0002-9297

Hernandex-Rodriguez, J, Murgia, G, Villar, I et al. (10 more authors) (2016) Description and validation of histological patterns and proposal of a dynamic model of inflammatory infiltration in giant-cell arteritis. Medicine, 95 (8). ISSN 0025-7974

David Carmona, F, Mackie, SL, Martin, J-E et al. (70 more authors) (2015) A Large-Scale Genetic Analysis Reveals a Strong Contribution of the HLA Class II Region to Giant Cell Arteritis Susceptibility. American Journal of Human Genetics, 96 (4). pp. 565-580. ISSN 0002-9297

Dasgupta, B, Cimmino, MA, Maradit-Kremers, H et al. (39 more authors) (2012) 2012 Provisional classification criteria for polymyalgia rheumatica: A European League Against Rheumatism/American College of Rheumatology collaborative initiative. Annals of the Rheumatic Diseases, 71 (4). pp. 484-492. ISSN 0003-4967